Cargando…

Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations

BACKGROUND: Invasive cribriform and intraductal carcinoma (CR/IDC) is associated with adverse outcome of prostate cancer patients. The aim of this study was to determine the molecular aberrations associated with CR/IDC in primary prostate cancer, focusing on genomic instability and somatic copy numb...

Descripción completa

Detalles Bibliográficos
Autores principales:	Böttcher, René, Kweldam, Charlotte F., Livingstone, Julie, Lalonde, Emilie, Yamaguchi, Takafumi N., Huang, Vincent, Yousif, Fouad, Fraser, Michael, Bristow, Robert G., van der Kwast, Theodorus, Boutros, Paul C., Jenster, Guido, van Leenders, Geert J. L. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751811/ https://www.ncbi.nlm.nih.gov/pubmed/29295717 http://dx.doi.org/10.1186/s12885-017-3976-z

Ejemplares similares

On cribriform prostate cancer
por: Kweldam, Charlotte F., et al.
Publicado: (2018)

Automated detection of cribriform growth patterns in prostate histology images
por: Ambrosini, Pierre, et al.
Publicado: (2020)

Intraductal carcinoma has a minimal impact on Grade Group assignment in prostate cancer biopsy and radical prostatectomy specimens
por: Rijstenberg, L. Lucia, et al.
Publicado: (2020)

Updating the Rotterdam Prostate Cancer Risk Calculator with Invasive Cribriform and/or Intraductal Carcinoma for Men with a Prior Negative Biopsy
por: Remmers, Sebastiaan, et al.
Publicado: (2021)

Large and small cribriform architecture have similar adverse clinical outcome on prostate cancer biopsies
por: Rijstenberg, L Lucia, et al.
Publicado: (2022)

Grading of prostate cancer: a work in progress
por: Kweldam, C F, et al.
Publicado: (2018)

Percentage Gleason pattern 4 and PI-RADS score predict upgrading in biopsy Grade Group 2 prostate cancer patients without cribriform pattern
por: van der Slot, Margaretha A., et al.
Publicado: (2022)

Somatic driver mutation prevalence in 1844 prostate cancers identifies ZNRF3 loss as a predictor of metastatic relapse
por: Fraser, Michael, et al.
Publicado: (2021)

Novel long non-coding RNAs are specific diagnostic and prognostic markers for prostate cancer
por: Böttcher, René, et al.
Publicado: (2015)

Are we ready to include invasive cribriform and intraductal carcinoma into the prostate cancer grade grouping system?
por: Xiao, Guang-Qian, et al.
Publicado: (2020)

Concordance of cribriform architecture in matched prostate cancer biopsy and radical prostatectomy specimens
por: Hollemans, Eva, et al.
Publicado: (2019)

Cribriform pattern in prostate tissues: Predictor for intraductal carcinoma of the prostate based on biopsy and radical prostatectomy pathology
por: Shiomi, Ei, et al.
Publicado: (2022)

Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis
por: Hollemans, Eva, et al.
Publicado: (2018)

Inter-observer variability of cribriform architecture and percent Gleason pattern 4 in prostate cancer: relation to clinical outcome
por: van der Slot, Margaretha A., et al.
Publicado: (2020)

The telomere length landscape of prostate cancer
por: Livingstone, Julie, et al.
Publicado: (2021)

Gene-expression analysis of gleason grade 3 tumor glands embedded in low- and high-risk prostate cancer
por: Hoogland, A. Marije, et al.
Publicado: (2016)

Cribriform architecture in radical prostatectomies predicts oncological outcome in Gleason score 8 prostate cancer patients
por: Hollemans, Eva, et al.
Publicado: (2020)

Cribriform ulcerations of the back
por: Aivaz, Marudeen, et al.
Publicado: (2020)

Prostate Cancer Morphologies: Cribriform Pattern and Intraductal Carcinoma Relations to Adverse Pathological and Clinical Outcomes—Systematic Review and Meta-Analysis
por: Osiecki, Rafał, et al.
Publicado: (2023)

Clinical outcome comparison of Grade Group 1 and Grade Group 2 prostate cancer with and without cribriform architecture at the time of radical prostatectomy
por: Hollemans, Eva, et al.
Publicado: (2020)

Prognostic Histopathological and Molecular Markers on Prostate Cancer Needle-Biopsies: A Review
por: Hoogland, A. Marije, et al.
Publicado: (2014)

Identification of intraductal carcinoma of the prostate on tissue specimens using Raman micro-spectroscopy: A diagnostic accuracy case–control study with multicohort validation
por: Grosset, Andrée-Anne, et al.
Publicado: (2020)

Progressive cribriform and zosteriform hyperpigmentation
por: Gutte, Rameshwar M.
Publicado: (2014)

Primary Cutaneous Cribriform Apocrine Carcinoma
por: Boettler, Michelle, et al.
Publicado: (2021)

Cribriform-morular variant of thyroid carcinoma
por: Cameselle-Teijeiro, J.M., et al.
Publicado: (2019)

Cribriform architecture outperforms Gleason pattern 4 percentage and tertiary Gleason pattern 5 in predicting the outcome of Grade Group 2 prostate cancer patients
por: Seyrek, Neslisah, et al.
Publicado: (2021)

A bedr way of genomic interval processing
por: Haider, Syed, et al.
Publicado: (2016)

Erratum to: A bedr way of genomic interval processing
por: Haider, Syed, et al.
Publicado: (2017)

Suspicious findings on micro-ultrasound imaging and early detection of prostate cancer
por: Ghai, Sangeet, et al.
Publicado: (2017)

Alternative prostate cancer grading systems incorporating percent pattern 4/5 (IQ-Gleason) and cribriform architecture (cGrade) improve prediction of outcome after radical prostatectomy
por: Seyrek, Neslisah, et al.
Publicado: (2022)

Post‐radiotherapy cribriform‐morular thyroid carcinoma
por: Or Koca, Arzu, et al.
Publicado: (2022)

Bad neighbours: hypoxia and genomic instability in prostate cancer
por: Ashton, Jack, et al.
Publicado: (2020)

Progressive cribriform and zosteriform hyperpigmentation: Where are we at present?
por: Goyal, Tarang
Publicado: (2013)

A rare case of breast invasive cribriform carcinoma
por: Tuan, Ho Xuan, et al.
Publicado: (2023)

Cribriform carcinoma arising in a benign phyllodes tumor
por: Shaaya, Elia Shazniza, et al.
Publicado: (2023)

Genomic Features and Clinical Implications of Intraductal Carcinoma of the Prostate
por: Kang, Minyong, et al.
Publicado: (2021)

Human PDE4D isoform composition is deregulated in primary prostate cancer and indicative for disease progression and development of distant metastases
por: Böttcher, René, et al.
Publicado: (2016)

The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma
por: van Leenders, Geert J.L.H., et al.
Publicado: (2020)

Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories
por: Taylor, Renea A., et al.
Publicado: (2017)

ShatterProof: operational detection and quantification of chromothripsis
por: Govind, Shaylan K, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_i6tb53hni8q19g6eegf05gpd6i